Biotech and Big Pharma Dominate this Week's Insider Buys

Odonate ODT's Chairman and CEO Kevin Tang has made open market purchases of more than $36 million in so far this June, including $10 million on the spot secondary at the highest price his paid all…


Notable Insider Buys Week Ending May 10, 2019

The market suffered its worse loss of the year, but that didn't stop some insiders buying their own stock. We highlight those over $200,000 in this report. Ticker Company Market Cap ($B)*…